
ME THERAPEUTICS ANNOUNCES IT HAS ENGAGED LUCOSKY BROOKMAN LLP TO EXPLORE A LISTING ON THE NASDAQ OR NYSE
ME Therapeutics Holdings Inc. (METX:CSE), a preclinical stage biotechnology company working on novel cancer fighting drugs in the field of Immuno-Oncology, is pleased to provide an overview and update on our current research and development programs.